Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 32

Trial Status

Completed7

Role Distribution

Principal Investigator5
Other Roles2
PI Rate71%

Activity Timeline

Clinical Trials (7)

NCT02363998Phase 3Completed
Open-Label, Safety Study of Lofexidine
Opioid Withdrawal
StudydirectorStart date: 2015-02-01
NCT01310296Phase 1Completed
Lofexidine ADME & Mass Balance in Volunteers
Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product
Principalinvestigator
NCT01437306Phase 1Completed
Lofexidine Food Effect Study in Healthy Volunteers
Healthy
Principalinvestigator
NCT01558934Phase 1Completed
Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
Methadone Withdrawal SyndromeOpioid Dependence
Studydirector
NCT01629446Phase 1Completed
Lofexidine Mass Balance in Volunteers
Normal Healthy Volunteers
Principalinvestigator
NCT01820442Phase 1Completed
Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
Buprenorphine Withdrawal SyndromeOpioid Dependence
Principalinvestigator
NCT01863186Phase 3Completed
Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
Acute Opioid Withdrawal SyndromeOpioid Dependence
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

James A Longstreth, PhD

US WorldMeds

Very Similar
6 trials

Shared therapeutic areas:

Opioid-Related DisordersMethadone Withdrawal SyndromeBuprenorphine Withdrawal Syndrome+3 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)USWM, LLC (dba US WorldMeds)
Collaborated on 5 trials
Similarity Score80%

Mark Leibowitz, MD

Worldwide Clinical Trials

Related
2 trials

Shared therapeutic areas:

Normal Healthy VolunteersNormal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)USWM, LLC (dba US WorldMeds)
Collaborated on 2 trials
Similarity Score28%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Waqar ahmed awan, Phd

Riphah International University

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

David Meeker, MD

Rhythm Pharmaceuticals, Inc.

Related
19 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Murad Alam, MD

Northwestern University

Related
65 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Ahmed Elshafeey, Ph.D. Pharma

Genuine Research Center

Related
34 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Suman Sheraz, PhD*

Riphah International University

Related
21 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT02363998Phase 3StudyDirector

Open-Label, Safety Study of Lofexidine

Opioid Withdrawal
Completed
NCT01310296Phase 1PrincipalInvestigator

Lofexidine ADME & Mass Balance in Volunteers

Normal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailability and Mass Balance Recovery of the Product
Completed
NCT01437306Phase 1PrincipalInvestigator

Lofexidine Food Effect Study in Healthy Volunteers

Healthy
Completed
NCT01558934Phase 1StudyDirector

Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients

Methadone Withdrawal SyndromeOpioid Dependence
Completed
NCT01629446Phase 1PrincipalInvestigator

Lofexidine Mass Balance in Volunteers

Normal Healthy Volunteers
Completed
NCT01820442Phase 1PrincipalInvestigator

Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients

Buprenorphine Withdrawal SyndromeOpioid Dependence
Completed
NCT01863186Phase 3PrincipalInvestigator

Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal

Acute Opioid Withdrawal SyndromeOpioid Dependence
Completed

All 7 trials loaded